Valeo Financial Advisors, LLC Novavax Inc Transaction History

Valeo Financial Advisors, LLC

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2021 Jul 22, 2021	SELL	$121.0 - $257.67 $5,082 - $10,822	-42 Closed	0 $0
Q1 2021 Apr 12, 2021	BUY	$112.98 - $319.93 $4,745 - $13,437	42 New	42 $8,000
Q4 2020 Feb 11, 2021	SELL	$78.74 - $139.5 $314 - $558	-4 Closed	0 $0
Q3 2020 Oct 28, 2020	SELL	$79.44 - $178.51 $5,481 - $12,317	-69 Reduced 94.52%	4 $0
Q2 2020 Jul 20, 2020	BUY	$13.86 - $83.61 $1,011 - $6,103	73 New	73 $6,000

286

84.8M

5.43M

Ticker NVAX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 78,215,104
Market Cap $713M
Description
Novavax, Inc., a biotechnology company, focuses on the discovery, development, and commercialization of vaccines to prevent serious infectious diseases and address health needs. The company's vaccine candidates include NVX-CoV2373, a coronavirus vaccine candidate that is in two Phase III trials, one Phase IIb trial, and one Phase I/II trial; Nan...

Get notified when there are updates to the investment portfolio of Valeo Financial Advisors, LLC, based on Form 13F filings with the SEC.

Stay updated on Valeo Financial Advisors, LLC with notifications on news.